The Role of Progesterone Receptors in Breast Cancer

被引：100

作者：

Li, Zhuo ^{[1
]}

Wei, Hongrui ^{[1
]}

Li, Siyan ^{[1
]}

Wu, Pei ^{[2
]}

Mao, Xiaoyun ^{[1
]}

机构：

[1] China Med Univ, Affiliated Hosp 1, Dept Breast Surg, 155 Nanjing North St, Shenyang 110001, Liaoning, Peoples R China

[2] China Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Shenyang, Liaoning, Peoples R China

来源：

DRUG DESIGN DEVELOPMENT AND THERAPY | 2022年 / 16卷

基金：

中国国家自然科学基金;

关键词：

progesterone receptor; breast cancer; endocrine therapy; SEX STEROID-HORMONES; N-TERMINAL REGION; ESTROGEN-RECEPTOR; DNA-BINDING; SIGNALING PATHWAYS; HUMAN-PREGNANCY; MICE LACKING; CROSS-TALK; EXPRESSION; TUMOR;

D O I：

10.2147/DDDT.S336643

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The progesterone receptor (PR) modulates estrogen receptors alpha (ER alpha) action in breast cancer; it is an upregulated target gene of ER, and its expression is dependent on estrogen. PR is also a valuable prognostic biomarker in breast cancer, especially in hormone-positive breast cancer. High expression of PR is more frequently observed in tumors with a better baseline prognosis (ie, luminal A) than tumors with a poor baseline prognosis (ie, luminal B). In the following review, we present the role of PR in breast cancer, including the genomic characteristics and pathways in breast cancer, PR and endocrine therapy.

引用

页码：305 / 314

页数：10

共 50 条

[31] Progesterone receptors - animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
Elizabeth Anderson
Breast Cancer Research, 4
[32] Prognostic role of oestrogen and progesterone receptors in patients with breast cancer: Relation to age and lymph node status
Collett, K
Hartveit, F
Skjaerven, R
Maehle, BO
JOURNAL OF CLINICAL PATHOLOGY, 1996, 49 (11) : 920 - 925
[33] Electrochemical Magnetoimmunosensor for Progesterone Receptor Determination. Application to the Simultaneous Detection of Estrogen and Progesterone Breast-cancer Related Receptors in Raw Cell Lysates.
Eletxigerra, U.
Martinez-Perdiguero, J.
Merino, S.
Barderas, R.
Ruiz-Valdepenas Montiel, V.
Villalonga, R.
Pingarron, J. M.
Campuzano, S.
ELECTROANALYSIS, 2016, 28 (08) : 1787 - 1794
[34] Characterization of estrogen receptor-negative/progesterone receptor-positive breast cancer
Shen, Tiansheng
Brandwein-Gensler, Margaret
Hameed, Omar
Siegal, Gene P.
Wei, Shi
HUMAN PATHOLOGY, 2015, 46 (11) : 1776 - 1784
[35] THE PROGNOSTIC VALUE OF ESTROGEN AND PROGESTERONE RECEPTORS IN FEMALE BREAST-CANCER - A SINGLE CENTER STUDY
MATHIESEN, O
BONDERUP, O
CARL, J
PANDURO, J
PEDERSEN, KO
ACTA ONCOLOGICA, 1991, 30 (06) : 691 - 695
[36] Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancer
Robertson, JFR
Cannon, PM
Nicholson, RI
Blamey, RW
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1996, 11 (01) : 29 - 35
[37] Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer
Leehy, Katherine A.
Anderson, Tarah M. Regan
Daniel, Andrea R.
Lange, Carol A.
Ostrander, Julie H.
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2016, 56 (03) : R99 - R114
[38] ERα-36 regulates progesterone receptor activity in breast cancer
Konan, Henri-Philippe
Kassem, Loay
Omarjee, Soleilmane
Surmieliova-Garnes, Ausra
Jacquemetton, Julien
Cascales, Elodie
Rezza, Amelie
Tredan, Olivier
Treilleux, Isabelle
Poulard, Coralie
Le Romancer, Muriel
BREAST CANCER RESEARCH, 2020, 22 (01)
[39] Molecular Imaging of Steroid Receptors in Breast Cancer
Keigley, Quinton J.
Fowler, Amy M.
O'Brien, Sophia R.
Dehdashti, Farrokh
CANCER JOURNAL, 2024, 30 (03) : 142 - 152
[40] 90 YEARS OF PROGESTERONE Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide
Dwyer, Amy R.
Thu H Truong
Ostrander, Julie H.
Lange, Carol A.
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2020, 65 (01) : T35 - T48

← 1 2 3 4 5 →